StemInov

Vandoeuvre-lès-nancy, France

StemInov develops stem cell therapies for inflammatory diseases, focusing on septic shock and ARDS.

$12.5M raised

Sep 2025

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has StemInov raised?

StemInov has raised $12.5M in total funding. The most recent round was Series A. The last funding was announced in September 2025.

Who are StemInov's investors?

StemInov's investors include Alsace Business Angels, Finovam Gestion, Angels Santé, Les Business Angels des Grandes √âcoles, ILP - Sadepar.

Where is StemInov headquartered?

StemInov is headquartered in Vandoeuvre-lès-nancy, France.

What does StemInov do?

StemInov develops stem cell therapies for inflammatory diseases, focusing on septic shock and ARDS.

What stage is StemInov at?

StemInov is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 25, 2025.

MLA

"StemInov — Funding & Investors." VCBacked, September 25, 2025, https://www.vcbacked.co/company/steminov. Accessed July 9, 2026.

APA

VCBacked. (2025). StemInov — Funding & Investors. Retrieved July 9, 2026, from https://www.vcbacked.co/company/steminov

Wikipedia (cite web)

{{cite web |title=StemInov — Funding & Investors |url=https://www.vcbacked.co/company/steminov |website=VCBacked |access-date=July 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 25, 2025.